- Home
- FPAY vs TECH Comparison
FPAY vs TECH Comparison
Compare FPAY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- TECH
- Stock Information
- Founded
- FPAY 2003
- TECH 1976
- Country
- FPAY United States
- TECH United States
- Employees
- FPAY N/A
- TECH N/A
- Industry
- FPAY Diversified Commercial Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FPAY Consumer Discretionary
- TECH Health Care
- Exchange
- FPAY Nasdaq
- TECH Nasdaq
- Market Cap
- FPAY N/A
- TECH 8.0B
- IPO Year
- FPAY N/A
- TECH 1989
- Fundamental
- Price
- FPAY $1.31
- TECH $50.78
- Analyst Decision
- FPAY Strong Buy
- TECH Buy
- Analyst Count
- FPAY 2
- TECH 8
- Target Price
- FPAY $3.25
- TECH $81.14
- AVG Volume (30 Days)
- FPAY 54.6K
- TECH 2.3M
- Earning Date
- FPAY 04-23-2025
- TECH 05-07-2025
- Dividend Yield
- FPAY N/A
- TECH 0.63%
- EPS Growth
- FPAY N/A
- TECH N/A
- EPS
- FPAY N/A
- TECH 0.98
- Revenue
- FPAY $139,800,732.00
- TECH $1,196,016,000.00
- Revenue This Year
- FPAY $12.05
- TECH $8.19
- Revenue Next Year
- FPAY N/A
- TECH $8.85
- P/E Ratio
- FPAY N/A
- TECH $51.85
- Revenue Growth
- FPAY 19.51
- TECH 4.46
- 52 Week Low
- FPAY $0.97
- TECH $46.44
- 52 Week High
- FPAY $2.37
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- FPAY 54.67
- TECH 42.06
- Support Level
- FPAY $0.99
- TECH $46.01
- Resistance Level
- FPAY $1.44
- TECH $53.54
- Average True Range (ATR)
- FPAY 0.09
- TECH 3.36
- MACD
- FPAY 0.02
- TECH 0.19
- Stochastic Oscillator
- FPAY 100.00
- TECH 57.33
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.